COLOPLAST-B (CBHD.DE) Stock Fundamental Analysis
FRA:CBHD - Deutsche Boerse Ag - DK0060448595 - Common Stock - Currency: EUR
Taking everything into account, CBHD scores 5 out of 10 in our fundamental rating. CBHD was compared to 59 industry peers in the Health Care Equipment & Supplies industry. While CBHD has a great profitability rating, there are some minor concerns on its financial health. CBHD has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year CBHD was profitable.
In the past year CBHD had a positive cash flow from operations.
CBHD had positive earnings in each of the past 5 years.
CBHD had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
CBHD has a better Return On Assets (9.45%) than 86.44% of its industry peers.
Looking at the Return On Equity, with a value of 25.33%, CBHD belongs to the top of the industry, outperforming 93.22% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 15.63%, CBHD belongs to the top of the industry, outperforming 96.61% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CBHD is significantly above the industry average of 8.57%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.45% | ||
| ROE | 25.33% | ||
| ROIC | 15.63% |
ROA(3y)11%
ROA(5y)18.91%
ROE(3y)37.52%
ROE(5y)45.66%
ROIC(3y)16.81%
ROIC(5y)28.33%
1.3 Margins
Looking at the Profit Margin, with a value of 16.35%, CBHD belongs to the top of the industry, outperforming 88.14% of the companies in the same industry.
In the last couple of years the Profit Margin of CBHD has declined.
CBHD has a better Operating Margin (26.90%) than 93.22% of its industry peers.
CBHD's Operating Margin has declined in the last couple of years.
CBHD has a Gross Margin of 67.52%. This is in the better half of the industry: CBHD outperforms 72.88% of its industry peers.
CBHD's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 26.9% | ||
| PM (TTM) | 16.35% | ||
| GM | 67.52% |
OM growth 3Y-6.25%
OM growth 5Y-2.74%
PM growth 3Y-9.04%
PM growth 5Y-2.84%
GM growth 3Y-0.46%
GM growth 5Y-0.05%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CBHD is creating value.
Compared to 1 year ago, CBHD has more shares outstanding
Compared to 5 years ago, CBHD has more shares outstanding
CBHD has a worse debt/assets ratio than last year.
2.2 Solvency
CBHD has an Altman-Z score of 4.21. This indicates that CBHD is financially healthy and has little risk of bankruptcy at the moment.
CBHD has a Altman-Z score of 4.21. This is in the better half of the industry: CBHD outperforms 76.27% of its industry peers.
The Debt to FCF ratio of CBHD is 4.64, which is a neutral value as it means it would take CBHD, 4.64 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 4.64, CBHD is doing good in the industry, outperforming 61.02% of the companies in the same industry.
CBHD has a Debt/Equity ratio of 0.96. This is a neutral value indicating CBHD is somewhat dependend on debt financing.
CBHD's Debt to Equity ratio of 0.96 is on the low side compared to the rest of the industry. CBHD is outperformed by 79.66% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.96 | ||
| Debt/FCF | 4.64 | ||
| Altman-Z | 4.21 |
ROIC/WACC2.56
WACC6.11%
2.3 Liquidity
CBHD has a Current Ratio of 1.02. This is a normal value and indicates that CBHD is financially healthy and should not expect problems in meeting its short term obligations.
CBHD's Current ratio of 1.02 is on the low side compared to the rest of the industry. CBHD is outperformed by 74.58% of its industry peers.
CBHD has a Quick Ratio of 1.02. This is a bad value and indicates that CBHD is not financially healthy enough and could expect problems in meeting its short term obligations.
CBHD's Quick ratio of 0.66 is on the low side compared to the rest of the industry. CBHD is outperformed by 74.58% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.02 | ||
| Quick Ratio | 0.66 |
3. Growth
3.1 Past
The earnings per share for CBHD have decreased by -7.50% in the last year.
Measured over the past 5 years, CBHD shows a small growth in Earnings Per Share. The EPS has been growing by 2.72% on average per year.
CBHD shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.89%.
CBHD shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.54% yearly.
EPS 1Y (TTM)-7.5%
EPS 3Y-0.25%
EPS 5Y2.72%
EPS Q2Q%-22.08%
Revenue 1Y (TTM)8.89%
Revenue growth 3Y11.64%
Revenue growth 5Y8.54%
Sales Q2Q%5.22%
3.2 Future
CBHD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.22% yearly.
The Revenue is expected to grow by 7.32% on average over the next years.
EPS Next Y14.67%
EPS Next 2Y13.5%
EPS Next 3Y13.5%
EPS Next 5Y11.22%
Revenue Next Year5.69%
Revenue Next 2Y6.84%
Revenue Next 3Y7.29%
Revenue Next 5Y7.32%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 29.43, CBHD can be considered very expensive at the moment.
Based on the Price/Earnings ratio, CBHD is valued a bit cheaper than the industry average as 66.10% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of CBHD to the average of the S&P500 Index (26.35), we can say CBHD is valued inline with the index average.
Based on the Price/Forward Earnings ratio of 21.10, the valuation of CBHD can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CBHD indicates a somewhat cheap valuation: CBHD is cheaper than 66.10% of the companies listed in the same industry.
CBHD's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.19.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.43 | ||
| Fwd PE | 21.1 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CBHD indicates a somewhat cheap valuation: CBHD is cheaper than 61.02% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CBHD indicates a somewhat cheap valuation: CBHD is cheaper than 74.58% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 26.33 | ||
| EV/EBITDA | 17.04 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CBHD does not grow enough to justify the current Price/Earnings ratio.
CBHD has an outstanding profitability rating, which may justify a higher PE ratio.
CBHD's earnings are expected to grow with 13.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.01
PEG (5Y)10.82
EPS Next 2Y13.5%
EPS Next 3Y13.5%
5. Dividend
5.1 Amount
CBHD has a Yearly Dividend Yield of 3.59%.
CBHD's Dividend Yield is rather good when compared to the industry average which is at 2.12. CBHD pays more dividend than 98.31% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.42, CBHD pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.59% |
5.2 History
The dividend of CBHD has a limited annual growth rate of 5.57%.
Dividend Growth(5Y)5.57%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
109.07% of the earnings are spent on dividend by CBHD. This is not a sustainable payout ratio.
CBHD's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP109.07%
EPS Next 2Y13.5%
EPS Next 3Y13.5%
FRA:CBHD (6/19/2025, 7:00:00 PM)
81.82
+0.88 (+1.09%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners27.78%
Inst Owner ChangeN/A
Ins Owners29.79%
Ins Owner ChangeN/A
Market Cap17.20B
Analysts67.41
Price Target101.04 (23.49%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.59% |
Yearly Dividend2.81
Dividend Growth(5Y)5.57%
DP109.07%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-15.35%
Min EPS beat(2)-15.38%
Max EPS beat(2)-15.32%
EPS beat(4)0
Avg EPS beat(4)-9.27%
Min EPS beat(4)-15.38%
Max EPS beat(4)-0.34%
EPS beat(8)0
Avg EPS beat(8)-7.43%
EPS beat(12)1
Avg EPS beat(12)-6.85%
EPS beat(16)2
Avg EPS beat(16)-6.39%
Revenue beat(2)0
Avg Revenue beat(2)-0.99%
Min Revenue beat(2)-1.56%
Max Revenue beat(2)-0.41%
Revenue beat(4)1
Avg Revenue beat(4)-0.5%
Min Revenue beat(4)-1.56%
Max Revenue beat(4)0.01%
Revenue beat(8)1
Avg Revenue beat(8)-1.53%
Revenue beat(12)2
Avg Revenue beat(12)-1.09%
Revenue beat(16)4
Avg Revenue beat(16)-0.74%
PT rev (1m)-13.04%
PT rev (3m)-20.3%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-7.36%
EPS NY rev (1m)0%
EPS NY rev (3m)0.46%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.63%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.66%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.43 | ||
| Fwd PE | 21.1 | ||
| P/S | 4.62 | ||
| P/FCF | 26.33 | ||
| P/OCF | 20.41 | ||
| P/B | 7.15 | ||
| P/tB | N/A | ||
| EV/EBITDA | 17.04 |
EPS(TTM)2.78
EY3.4%
EPS(NY)3.88
Fwd EY4.74%
FCF(TTM)3.11
FCFY3.8%
OCF(TTM)4.01
OCFY4.9%
SpS17.73
BVpS11.44
TBVpS-7.9
PEG (NY)2.01
PEG (5Y)10.82
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.45% | ||
| ROE | 25.33% | ||
| ROCE | 19.74% | ||
| ROIC | 15.63% | ||
| ROICexc | 15.97% | ||
| ROICexgc | 87.72% | ||
| OM | 26.9% | ||
| PM (TTM) | 16.35% | ||
| GM | 67.52% | ||
| FCFM | 17.53% |
ROA(3y)11%
ROA(5y)18.91%
ROE(3y)37.52%
ROE(5y)45.66%
ROIC(3y)16.81%
ROIC(5y)28.33%
ROICexc(3y)17.22%
ROICexc(5y)29.72%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)21.23%
ROCE(5y)39.82%
ROICexcg growth 3Y7.74%
ROICexcg growth 5Y2.01%
ROICexc growth 3Y-30.17%
ROICexc growth 5Y-21.96%
OM growth 3Y-6.25%
OM growth 5Y-2.74%
PM growth 3Y-9.04%
PM growth 5Y-2.84%
GM growth 3Y-0.46%
GM growth 5Y-0.05%
F-Score6
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.96 | ||
| Debt/FCF | 4.64 | ||
| Debt/EBITDA | 1.96 | ||
| Cap/Depr | 105.92% | ||
| Cap/Sales | 5.09% | ||
| Interest Coverage | 8.47 | ||
| Cash Conversion | 71.35% | ||
| Profit Quality | 107.24% | ||
| Current Ratio | 1.02 | ||
| Quick Ratio | 0.66 | ||
| Altman-Z | 4.21 |
F-Score6
WACC6.11%
ROIC/WACC2.56
Cap/Depr(3y)114.16%
Cap/Depr(5y)140.02%
Cap/Sales(3y)5.02%
Cap/Sales(5y)6.04%
Profit Quality(3y)58.21%
Profit Quality(5y)66.95%
High Growth Momentum
Growth
EPS 1Y (TTM)-7.5%
EPS 3Y-0.25%
EPS 5Y2.72%
EPS Q2Q%-22.08%
EPS Next Y14.67%
EPS Next 2Y13.5%
EPS Next 3Y13.5%
EPS Next 5Y11.22%
Revenue 1Y (TTM)8.89%
Revenue growth 3Y11.64%
Revenue growth 5Y8.54%
Sales Q2Q%5.22%
Revenue Next Year5.69%
Revenue Next 2Y6.84%
Revenue Next 3Y7.29%
Revenue Next 5Y7.32%
EBIT growth 1Y6.6%
EBIT growth 3Y4.66%
EBIT growth 5Y5.57%
EBIT Next Year23.01%
EBIT Next 3Y14.31%
EBIT Next 5Y12.57%
FCF growth 1Y33.03%
FCF growth 3Y-24.77%
FCF growth 5Y-17.33%
OCF growth 1Y28.46%
OCF growth 3Y-19.49%
OCF growth 5Y-8.71%